Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China

Tropical Medicine and International Health

Volumn 19, Issue 10, 2014, Pages 1259-1266

  Zhang, Dan ^a   Liu, Beizhong ^a   Wang, Yufeng ^b   Pang, Yu ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

China; Molecular characterisation; Multidrug resistance; Tuberculosis

Indexed keywords

ETHAMBUTOL; GENOMIC DNA; ISONIAZID; KANAMYCIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; BACTERIAL DNA; BACTERIAL PROTEIN; TUBERCULOSTATIC AGENT;

ANTIBIOTICS; DRUG RESISTANCE; GENETIC ANALYSIS; GENETIC MARKER; MOLECULAR ANALYSIS; MUTATION; PHENOTYPE; PROTEIN; TUBERCULOSIS;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; CHINA; CODON; DNA SEQUENCE; DRUG SENSITIVITY; EMBB GENE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE; GENETIC RESISTANCE; GENETIC SCREENING; GYRA GENE; GYRB GENE; HUMAN; INHA GENE; KATG PROTEIN GENE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PROMOTER REGION; SEQUENCE ALIGNMENT; BACTERIAL GENE; CARACTERIZACIÓN MOLECULAR; CARACTÉRISATION MOLÉCULAIRE; CHINE; GENETICS; MICROBIOLOGY; MOLECULAR CHARACTERISATION; MULTIDRUG RESISTANCE; MULTIRÉSISTANCE; MULTIRRESISTENCIA; MUTATION; TUBERCULOSE; TUBERCULOSIS;

CHINA; CHONGQING;

CARACTERIZACIÓN MOLECULAR; CARACTÉRISATION MOLÉCULAIRE; CHINA; CHINE; MOLECULAR CHARACTERISATION; MULTIDRUG RESISTANCE; MULTIRÉSISTANCE; MULTIRRESISTENCIA; TUBERCULOSE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHAMBUTOL; GENES, BACTERIAL; HUMANS; KANAMYCIN; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; PHENOTYPE; SEQUENCE ANALYSIS, DNA; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84908871220     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12359     Document Type: Article

References (36)

1. Abebe G, Paasch F, Apers L et al. (2011) Tuberculosis drug resistance testing by molecular methods: opportunities and challenges in resource limited settings. Journal of Microbiological Methods 84, 155-160.
2. Alangaden GJ, Kreiswirth BN, Aouad A et al. (1998) Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 42, 1295-1297.
3. Almeida Da Silva PE & Palomino JC (2011) Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. Journal of Antimicrobial Chemotherapy 66, 1417-1430.
4. Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A & Stakenas P (2003) Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrobial Agents and Chemotherapy 47, 2009-2011.
5. Banerjee A, Dubnau E, Quemard A et al. (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230.
6. Campbell PJ, Morlock GP, Sikes RD et al. (2011) Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 55, 2032-2041.
7. Chen Q, Pang Y, Liang Q et al. (2014). Molecular characteristics of MDR Mycobacterium tuberculosis strains isolated in Fujian, China. Tuberculosis 94, 159-161.
8. Cheng S, Cui Z, Li Y & Hu Z. (2014) Diagnostic accuracy of a molecular drug susceptibility testing method for the TB drug, ethambutol: a systematic review and meta-analysis. Journal of Clinical Microbiology doi: 10.1128.
9. Falzon D, Jaramillo E, Schunemann HJ et al. (2011) WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. European Respiratory Journal 38, 516-528.
10. Guo JH, Xiang WL, Zhao QR et al. (2008) Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Sichuan Province in China. Japanese Journal of Infectious Diseases 61, 264-268.
11. Iwamoto T, Yoshida S, Suzuki K & Wada T (2008) Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrobial Agents and Chemotherapy 52, 3805-3809.
12. Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F & Rigouts L (2009) High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrobial Agents and Chemotherapy 53, 5064-5068.
13. Lee AS, Lim IH, Tang LL, Telenti A & Wong SY (1999) Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrobial Agents and Chemotherapy 43, 2087-2089.
14. Luo T, Zhao M, Li X et al. (2010) Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. Antimicrobial Agents and Chemotherapy 54, 1075-1081.
15. Madison B, Robinson-Dunn B, George I et al. (2002) Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. Journal of Clinical Microbiology 40, 3976-3979.
16. Mallik I, Arabiat S, Pasche J, Bolton MD, Patel JS & Gudmestad NC (2014) Molecular characterization and detection of mutations associated with resistance to succinate dehydrogenase inhibiting (SDHI) fungicides in Alternaria solani. Phytopathology 104, 40-49.
17. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L & Vyshnevskiy B (2002) High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia 1996 to 2001. Antimicrobial Agents and Chemotherapy 46, 1417-1424.
18. Pang Y, Zhou Y, Wang S et al. (2011) A novel method based on high resolution melting (HRM) analysis for MIRU-VNTR genotyping of Mycobacterium tuberculosis. Journal of Microbiological Methods 86, 291-297.
19. Pang Y, Zhou Y, Zhao B et al. (2012) Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS ONE 7, e32976.
20. Pang Y, Xia H, Zhang Z et al. (2013) Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. Journal of Clinical Microbiology 51, 1707-1713.
21. Parsons LM, Somoskövi Á, Gutierrez C et al. (2011) Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clinical Microbiology Reviews 24, 314-350.
22. Plinke C, Rusch-Gerdes S & Niemann S (2006) Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrobial Agents and Chemotherapy 50, 1900-1902.
23. Plinke C, Cox HS, Kalon S et al. (2009) Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results. Tuberculosis 89, 448-452.
24. Poudel A, Nakajima C, Fukushima Y et al. (2012) Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal. Antimicrobial Agents and Chemotherapy 56, 2831-2836.
25. Ramaswamy S & Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tubercle and Lung Disease 79, 3-29.
26. van Soolingen D, de Haas PE, van Doorn HR, Kuijper E, Rinder H & Borgdorff MW (2000) Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. Journal of Infectious Diseases 182, 1788-1790.
27. World Health Organization. (2008) TB Drug Resistance in The World. In Report no. 4. WHO/HTM/TB/2008.394. World Health Organization, Geneva, Switzerland.
28. World Health Organization. (2013a) Global Tuberculosis Report 2013. WHO/HTM/TB/2013.11. World Health Organization, Geneva, Switzerland.
29. World Health Organization. (2013b) The Use of Molecular Line Probe Assay for The Detection of Resistance to Second-line TB Drugs. WHO/HTM/TB/2013.01. World Health Organization, Geneva, Switzerland.
30. Yuan X, Zhang T, Kawakami K et al. (2012) Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. Journal of Clinical Microbiology 50, 2404-2413.
31. Yue J, Shi W, Xie J, Li Y, Zeng E & Wang H (2003) Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. Journal of Clinical Microbiology 41, 2209-2212.
32. Zhang Y, Heym B, Allen B, Young D & Cole S (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591-593.
33. Zhang D, An J, Wang J et al. (2013) Molecular typing and drug susceptibility of Mycobacterium tuberculosis isolates from Chongqing Municipality, China. Infection, Genetics and Evolution 13, 310-316.
34. Zhang Z, Lu J, Wang Y, Pang Y & Zhao Y (2014a) Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China. Antimicrobial Agents and Chemotherapy 58, 364-369.
35. Zhang Z, Wang Y, Pang Y & Kam KM (2014b) Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 52, 638-641.
36. Zhao Y, Xu S, Wang L et al. (2012) National survey of drug-resistant tuberculosis in China. New England Journal of Medicine 366, 2161-2170.